Scientists propose CDK2 enzyme as new target for cancer therapy
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
Study sets benchmark for treatment of advanced cervical cancer
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
Armed robbery in Revesby14h
China's CSCO BC Guidelines: New Breast Cancer Insights
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines mark a significant milestone in breast cancer treatment, seamlessly ...
Relay Therapeutics: A Precision Oncology Play Worth The Risk
Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...